Matthew Blunt

University of Southampton

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (8)

Francesco Forconi

University of Southampton

UNITED KINGDOM

View details

Salim Khakoo

University of Southampton Faculty of Medicine

UNITED KINGDOM

View details

Andres Felipe Vallejo

University of Southampton

UNITED KINGDOM

View details

Marta Ewa Polak

Associate Professor, Sir Henry Dale Wellcome Trust Fellow

University of Southampton

UNITED KINGDOM

View details

Mark Cragg

Prof. at Faculty of Engineering and Physical Sciences

University of Southampton

UNITED KINGDOM

View details

Peter Johnson

University of Southampton

UNITED KINGDOM

View details

Laura Grace Bartlett

University of Southampton

UNITED KINGDOM

View details

Professor Jonathan C Strefford

Professor of Molecular Oncology

University of Southampton

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthew Blunt

Research Interests

Explore related searches

Contact this professor

Articles (15)

Modulation of anti-tumour immunity by XPO1 inhibitors

CD40L and IL-4 suppress NK cell-mediated ADCC through the HLA-E:NKG2A axis

NK Cells in Health and Disease

NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity

The nuclear export protein XPO1 provides a peptide ligand for natural killer cells

Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity.

Targeting CD161 in B-cell malignancies

Harnessing natural killer cell effector function against cancer

Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL

XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression.

Targeting KIR as a novel approach to improve CAR-NK cell function

Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer

KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity

Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors

Activating killer cell immunoglobulin‐like receptors: Detection, function and therapeutic use

Collaborators (8)

Francesco Forconi

Salim Khakoo

Andres Felipe Vallejo

Marta Ewa Polak

Mark Cragg

Peter Johnson

Laura Grace Bartlett

Professor Jonathan C Strefford

Make your next move.